Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V0WE
|
|||
| Drug Name |
NIA-114
|
|||
| Indication | Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0] | Clinical trial | [1] | |
| Company |
Niadyne Pharma Fort Worth, TX
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hydroxycarboxylic acid receptor 3 (HCAR3) | Target Info | Agonist | [1] |
| Nicotinic acid receptor (HCAR2) | Target Info | Agonist | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.